CV Therapeutics, Inc. (NASDAQ:CVTX.DL)
CAPS Rating:
A biopharmaceutical company focused on the discovery, development and commercialization of new small molecule drugs for the treatment of cardiovascular diseases.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
No players have picked CVTX.DL yet. Tell us why you think CVTX.DL will outperform or underperform the market.
RSS Headlines
Fool UK
